Clinical trial
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating…
NCT00403182 · Technical University of Munich, Other · Withdrawn
Key facts
| NCT number | NCT00403182 |
|---|---|
| Title | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer |
| Official title | The CORE Study (Chemotherapy OR Endocrine Treatment First?) A Randomized Study by the Scandinavian Breast Group [CORE] |
| Lead sponsor | Technical University of Munich, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | chemotherapy, letrozole |
| Enrollment | 0 |
| Start date | May 1, 2006 |
| First posted | Nov 23, 2006 |
| Last update posted | Jun 1, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: